Education and Training
- Ph.D., University of California at Davis, 2004
Zolla-Pazner, Susan, Allan C. deCamp, Timothy Cardozo, Nicos Karasavvas, Raphael Gottardo, Constance Williams, Daryl E. Morris, et al. “Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial..” Plos One 8, no. 1 (2013). https://doi.org/10.1371/journal.pone.0053629.
Imholte, G. C., R. Sauteraud, B. Korber, R. T. Bailer, E. T. Turk, X. Shen, G. D. Tomaras, et al. “A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling.” Journal of Immunological Methods 395, no. 1–2 (2013): 1–13. https://doi.org/10.1016/j.jim.2013.06.001.
Gottardo, Raphael, Robert T. Bailer, Bette T. Korber, S. Gnanakaran, Joshua Phillips, Xiaoying Shen, Georgia D. Tomaras, et al. “Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial..” Plos One 8, no. 9 (2013). https://doi.org/10.1371/journal.pone.0075665.
Karasavvas, Nicos, Erik Billings, Mangala Rao, Constance Williams, Susan Zolla-Pazner, Robert T. Bailer, Richard A. Koup, et al. “The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120..” Aids Res Hum Retroviruses 28, no. 11 (November 2012): 1444–57. https://doi.org/10.1089/aid.2012.0103.
Haynes, Barton F., Peter B. Gilbert, M Juliana McElrath, Susan Zolla-Pazner, Georgia D. Tomaras, S Munir Alam, David T. Evans, et al. “Immune-correlates analysis of an HIV-1 vaccine efficacy trial..” N Engl J Med 366, no. 14 (April 5, 2012): 1275–86. https://doi.org/10.1056/NEJMoa1113425.
Tomaras, Georgia D., James M. Binley, Elin S. Gray, Emma T. Crooks, Keiko Osawa, Penny L. Moore, Nancy Tumba, et al. “Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals..” J Virol 85, no. 21 (November 2011): 11502–19. https://doi.org/10.1128/JVI.05363-11.
Zhu, Zhongyu, Haiyan Rebekah Qin, Weizao Chen, Qi Zhao, Xiaoying Shen, Robert Schutte, Yanping Wang, et al. “Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies..” J Virol 85, no. 21 (November 2011): 11401–8. https://doi.org/10.1128/JVI.05312-11.
Zhu, Z., H. R. Qin, W. Chen, Q. Zhao, X. Shen, R. Schutte, Y. Wang, et al. “2F5-like Cross-Reactive HIV-1-Neutralizing Monoclonal Antibodies with Low Number of Somatic Mutations.” In Aids Research and Human Retroviruses, 27:A9–A9. MARY ANN LIEBERT INC, 2011.
Fouda, Genevieve G., Nicole L. Yates, Justin Pollara, Xiaoying Shen, Glenn R. Overman, Tatenda Mahlokozera, Andrew B. Wilks, et al. “HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies..” J Virol 85, no. 18 (September 2011): 9555–67. https://doi.org/10.1128/JVI.05174-11.
Spearman, Paul, Michelle A. Lally, Marnie Elizaga, David Montefiori, Georgia D. Tomaras, M Juliana McElrath, John Hural, et al. “A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers..” J Infect Dis 203, no. 8 (April 15, 2011): 1165–73. https://doi.org/10.1093/infdis/jiq175.